首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1469793

全球診斷專用抗體市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Diagnostic Specialty Antibodies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球診斷專用抗體市場需求預計將從 2023 年的 280.1 億美元達到 2032 年近 468.8 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.89%。

診斷專用抗體是在實驗室中產生的蛋白質，旨在與特定目標分子（例如蛋白質、荷爾蒙或感染因子）結合，以用於診斷目的。這些抗體用於各種免疫測定技術，包括酵素連結免疫吸附測定 (ELISA)、蛋白質印跡和免疫組織化學，以檢測和量化與疾病、感染和生理狀況相關的生物標記。這些抗體是臨床實驗室、研究機構和醫療機構診斷疾病、監測治療反應和進行醫學研究的重要工具。它們在檢測和識別生物樣本中的特定抗原或分析物方面具有高特異性、靈敏度和重現性。

市場動態

傳染病、自體免疫疾病和癌症的日益普及正在推動對先進診斷技術的需求，這些技術依賴特殊抗體來準確、及時地檢測和監測疾病。特種抗體在各種診斷測定中發揮著至關重要的作用，包括酶聯免疫吸附測定(ELISA)、免疫組織化學(IHC)、流式細胞儀和分子診斷，使醫療保健提供者能夠以高靈敏度和特異性識別特定生物標記和病原體。此外，個人化醫療和標靶治療的日益普及正在推動對伴隨診斷的需求，這些診斷需要專門的抗體來進行患者分層、治療選擇和治療監測。此外，抗體工程、生產方法和純化技術的技術進步增強了特種抗體的性能、特異性和重現性，擴大了其在診斷測試中的應用。

此外，製藥和生物技術公司不斷增加對研發活動的投資，以開發新型生物標記、治療標靶和診斷測定，推動了診斷專用抗體市場的成長。此外，對快速診斷測試、即時測試解決方案和利用特殊抗體的多重檢測的需求不斷成長，正在為市場擴張創造機會。此外，新興經濟體對早期疾病檢測、預防性篩檢計畫和醫療基礎設施發展的關注正在推動診斷實驗室、醫院和診所採用診斷專用抗體。此外，診斷產業主要參與者之間的策略合作、夥伴關係和併購正在促進技術轉移、產品創新和市場擴張。然而，診斷技術和替代測試方法的進步可能會在未來幾年挑戰診斷專用抗體市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球診斷專用抗體市場的每個細分市場進行了包容性評估。診斷專用抗體產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

診斷專用抗體市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按抗體類型

單株抗體
多株抗體抗體
重組多株抗體抗體

按申請

肝炎診斷
結核病診斷
登革熱診斷
腫瘤診斷
愛滋病毒診斷
傳染病診斷
其他

按最終用戶

醫院
診斷實驗室
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲診斷專用抗體市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。診斷專用抗體市場的主要參與者包括 Abcam plc、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、Sanofi、Bio-Rad Laboratories, Inc.、Boehringer Ingelheim International GmbH、Agilent Technologies, Inc.、Aytu BioScience, Inc.本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：診斷專用抗體公司的競爭格局

診斷專用抗體市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Abcam plc

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

Abbott Laboratories

公司簡介
公司收入
產品
最近的發展

Sanofi

公司簡介
公司收入
產品
最近的發展

Bio-Rad Laboratories Inc.

公司簡介
公司收入
產品
最近的發展

Boehringer Ingelheim International GmbH

公司簡介
公司收入
產品
最近的發展

Agilent Technologies Inc.

公司簡介
公司收入
產品
最近的發展

Aytu BioScience Inc.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114191

The global demand for Diagnostic Specialty Antibodies Market is presumed to reach the market size of nearly USD 46.88 Billion by 2032 from USD 28.01 Billion in 2023 with a CAGR of 5.89% under the study period 2024 - 2032.

Diagnostic specialty antibodies are proteins produced in the laboratory designed to bind to specific target molecules, such as proteins, hormones, or infectious agents, for diagnostic purposes. These antibodies are used in various immunoassay techniques, including enzyme-linked immunosorbent assays (ELISA), western blotting, and immunohistochemistry, to detect and quantify biomarkers associated with diseases, infections, and physiological conditions. These antibodies are crucial tools in clinical laboratories, research institutions, and healthcare settings for diagnosing diseases, monitoring treatment responses, and conducting medical research. They provide high specificity, sensitivity, and reproducibility in detecting and identifying specific antigens or analytes in biological samples.

MARKET DYNAMICS

The increasing prevalence of infectious diseases, autoimmune disorders, and cancer is driving the demand for advanced diagnostic techniques that rely on specialty antibodies for accurate and timely disease detection and monitoring. Specialty antibodies play a crucial role in various diagnostic assays, including enzyme-linked immunosorbent assays (ELISA), immunohistochemistry (IHC), flow cytometry, and molecular diagnostics, enabling healthcare providers to identify specific biomarkers and pathogens with high sensitivity and specificity. Moreover, the growing adoption of personalized medicine and targeted therapies is fuelling the demand for companion diagnostics that require specialized antibodies for patient stratification, treatment selection, and therapeutic monitoring. Additionally, technological advancements in antibody engineering, production methods, and purification techniques enhance specialty antibodies' performance, specificity, and reproducibility, expanding their applications in diagnostic testing.

Furthermore, pharmaceutical and biotechnology companies' increasing investments in research & development activities to develop novel biomarkers, therapeutic targets, and diagnostic assays drive diagnostic specialty antibodies market growth. Moreover, the rising demand for rapid diagnostic tests, point-of-care testing solutions, and multiplexed assays that utilize specialty antibodies is creating opportunities for market expansion. Furthermore, the focus on early disease detection, preventive screening programs, and healthcare infrastructure development in emerging economies is driving the adoption of diagnostic specialty antibodies in diagnostic laboratories, hospitals, and clinics. Furthermore, strategic collaborations, partnerships, and mergers & acquisitions among key players in the diagnostic industry are facilitating technology transfer, product innovation, and market expansion. However, advancements in diagnostic technologies and alternative testing methods may challenge the diagnostic specialty antibodies market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of diagnostic specialty antibodies. The growth and trends of diagnostic specialty antibodies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the diagnostic specialty antibodies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Antibody Type

Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies

By Application

Hepatitis Diagnostics
Tuberculosis Diagnostics
Dengue Diagnostics
Oncology Diagnostics
HIV Diagnostics
Infectious Disease Diagnostics
Others

By End-User

Hospitals
Diagnostic Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Diagnostic Specialty Antibodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Diagnostic Specialty Antibodies market include Abcam plc, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sanofi, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., Aytu BioScience, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DIAGNOSTIC SPECIALTY ANTIBODIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Antibody Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY ANTIBODY TYPE

5.1 Overview by Antibody Type
5.2 Historical and Forecast Data
5.3 Analysis by Antibody Type
5.4 Monoclonal Antibodies Historic and Forecast Sales by Regions
5.5 Polyclonal Antibodies Historic and Forecast Sales by Regions
5.6 Recombinant Polyclonal Antibodies Historic and Forecast Sales by Regions

6 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Hepatitis Diagnostics Historic and Forecast Sales by Regions
6.5 Tuberculosis Diagnostics Historic and Forecast Sales by Regions
6.6 Dengue Diagnostics Historic and Forecast Sales by Regions
6.7 Oncology Diagnostics Historic and Forecast Sales by Regions
6.8 HIV Diagnostics Historic and Forecast Sales by Regions
6.9 Infectious Disease Diagnostics Historic and Forecast Sales by Regions
6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE DIAGNOSTIC SPECIALTY ANTIBODIES COMPANIES

9.1. Diagnostic Specialty Antibodies Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF DIAGNOSTIC SPECIALTY ANTIBODIES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Abcam plc
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Abbott Laboratories
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Sanofi
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Bio-Rad Laboratories Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Boehringer Ingelheim International GmbH
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Agilent Technologies Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Aytu BioScience Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments